easyJet Edges Higher as Markets Watch Takeover Chatter

easyJet Edges Higher as Markets Watch Takeover Chatter

June 13, 2026

London, June 13, 2026, 21:03 (BST)

  • easyJet closed Friday at 500.00p, gaining 2.04% and outpacing the FTSE 250, which added 1.55%.
  • Air France-KLM CEO Ben Smith told reporters the group isn’t actively reviewing easyJet, but said the British airline’s assets look attractive.
  • Castlelake faces a June 26 deadline to put in a formal bid or pull out.

easyJet plc ended the week up, with takeout talk still the main driver for the FTSE 250 airline. Shares settled at 500.00p on Friday, adding 2.04%. MarketScreener data showed a 6.00% gain for the week, but the stock is still off 2.08% for the year. Hargreaves Lansdown pegged the market cap around £3.74 billion and reported trading volume over 10.8 million shares.

Air France-KLM CEO Ben Smith said at the Paris Air Forum that Castlelake has not approached the airline group to join a bid for easyJet. Smith said Air France-KLM is not actively looking at easyJet, but he still called easyJet’s assets “amazing.” “There are some amazing assets that easyJet has,” Smith said. Reuters

The difference matters for easyJet’s share price. Castlelake, a U.S. investment firm, said it’s thinking about a possible bid above 403.23p per share, but easyJet’s board hasn’t received a formal offer. The stock is now well above that level, which suggests investors are expecting either a much higher bid, another strategic angle, or an independent recovery instead of a small premium takeover.

Castlelake has until June 26 to either announce a firm bid or walk away, as required by UK takeover law. Airline ownership rules could get in the way. Reuters said analysts doubt a full buyout would work, since EU and UK rules stop outsiders from owning more than 50% of an airline. Barclays’ Andrew Lobbenberg told Reuters any deal “need[s] to have regard” for those restrictions. Reuters

EasyJet’s bull case is tied to its ownership of limited aviation assets like airport slots and growth in its holidays unit. Some analysts point to takeover interest as proof shares are undervalued. Morningstar said analyst Loredana Muharremi cut her fair value target to £5.74 from £6.70, but still saw the shares as undervalued with the price near £4.68 earlier this week. Reuters mentioned Barclays, which also sees easyJet’s share price as consistently below the value of its assets.

easyJet’s outlook is still tied to fuel prices, booking trends, and geopolitical risk. The carrier posted a headline pre-tax loss of £552 million for the half year to March 31, 2026, widening from a £394 million loss last year. “Headline” is easyJet’s own adjusted figure, before tax. Passenger numbers in the period rose 6% to 42 million, with load factor up to 90%. The company pointed to higher fuel bills and legal provisions. Investegate

Fuel is still a key driver for the stock, with airlines typically hedging to blunt cost swings, though that doesn’t cover everything. easyJet has flagged before that its fuel bill and demand are harder to predict since the Middle East conflict. Last month, Reuters said the airline’s guidance for the year stayed murky, with higher fuel bills and softer summer bookings dragging on its outlook.

easyJet doesn’t look cheap right now, at least not on the facts at hand. Takeover speculation and asset value keep a floor under the shares, but with Friday’s 500p close, a lot of M&A speculation is already in the price. Castlelake could walk away June 26. If that happens, or if summer bookings and fuel costs fall short, the stock may go back to trading on earnings risk, not bid hopes.

Stock Market Today

  • Haleon Shares Rise Amid Buybacks and U.S. Growth Momentum Ahead of July Earnings
    June 13, 2026, 4:38 PM EDT. Haleon PLC shares rose 0.84% to 336.8p in London as investors monitor its ongoing £500 million buyback programme and U.S. market recovery. The company plans to release H1 2026 results on July 30, a key event for shareholders. Haleon, known for Sensodyne and Panadol, reported 2.2% organic revenue growth in Q1 and reaffirmed full-year guidance of 3%-5% revenue growth. Despite weaker cold-and-flu sales impacting Respiratory Health by 3.4%, Oral Health revenue rose 8.3%, driven by core brands. Analysts maintain a positive outlook, with a median 12-month price target 25% above current levels. Haleon's market cap stands near £29.74 billion with a P/E of 18.21, reflecting steady investor confidence amid cost pressures and competitive markets.